PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
出版年份 2017 全文链接
标题
PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-09
DOI
10.1038/s41598-017-02162-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells
- (2016) Shuntaro Tsukamoto et al. BRITISH JOURNAL OF HAEMATOLOGY
- FOXO3 is essential for CD44 expression in pancreatic cancer cells
- (2016) M Kumazoe et al. ONCOGENE
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer
- (2015) Takashi Nojiri et al. CHEST
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- New insights into pancreatic cancer stem cells
- (2015) Chinthalapally V Rao World Journal of Stem Cells
- Intracellular autofluorescence: a biomarker for epithelial cancer stem cells
- (2014) Irene Miranda-Lorenzo et al. NATURE METHODS
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Histological and prognostic importance of CD44+/CD24+/EpCAM+expression in clinical pancreatic cancer
- (2013) Yusuke Ohara et al. CANCER SCIENCE
- DCLK1 Marks a Morphologically Distinct Subpopulation of Cells With Stem Cell Properties in Preinvasive Pancreatic Cancer
- (2013) Jennifer M. Bailey et al. GASTROENTEROLOGY
- How valid are claims for synergy in published clinical studies?
- (2012) A. Ocana et al. ANNALS OF ONCOLOGY
- Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
- (2012) Tait D. Shanafelt et al. CANCER
- Pancreatic cancer stem cells: Emerging target for designing novel therapy
- (2012) Yiwei Li et al. CANCER LETTERS
- Identification of Pancreatic Cancer Stem Cells and Selective Toxicity of Chemotherapeutic Agents
- (2012) Rama Adikrisna et al. GASTROENTEROLOGY
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells
- (2011) Barbara Varnum-Finney et al. JOURNAL OF CLINICAL INVESTIGATION
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma
- (2011) Chigusa Morizane et al. PANCREAS
- Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-transretinoic acid-induced neutrophil differentiation via death-associated protein kinase 2
- (2010) Adrian Britschgi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Solid-Phase Synthesis of a Combinatorial Methylated (±)-Epigallocatechin Gallate Library and the Growth-Inhibitory Effects of these Compounds on Melanoma B16 Cells
- (2010) Hiroshi Tanaka et al. Chemistry-An Asian Journal
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Polyphenon E®: a new treatment for external anogenital warts
- (2009) S. Tatti et al. BRITISH JOURNAL OF DERMATOLOGY
- Two populations of endochondral osteoblasts with differential sensitivity to Hedgehog signalling
- (2009) C. L. Hammond et al. DEVELOPMENT
- 67-kDa Laminin Receptor in Human Bile Duct Carcinoma
- (2009) D. Li et al. EUROPEAN SURGICAL RESEARCH
- Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia
- (2009) Tait D. Shanafelt et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Functions of the 37/67-kd Laminin Receptor Make It a Suitable Target for Novel Cancer Gene Therapy
- (2009) Jonathan Scheiman et al. MOLECULAR THERAPY
- A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult Myogenesis
- (2008) Andrew S. Brack et al. Cell Stem Cell
- Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now